KOSPIFood & Beverage003920

Namyang Dairy Products

₩41,650▼ 1.88%2026-11-18 close
Market Cap
₩236.3B
Turnover
₩25,986,650
Volume
626 shares
Shares out.
5.7M
PER
26.5×
PBR
0.3×
EPS
₩1,562
Dividend Yield
3.45%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩1,428 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit Turnaround Holds, Cash Flow Remains the Test

Namyang Dairy Products turned profitable at the operating level in 2025, and operating profit has risen for two straight quarters through Q3 2026, but the earnings base is still thin and operating cash flow turned negative in the first three quarters of 2026.

  1. 1

    Operating profit for 2025 was KRW 5.17 billion, a turn to profitability after the operating loss narrowed to KRW 9.81 billion in 2024.

  2. 2

    Q3 2026 revenue reached KRW 257.6 billion, up 8.5% year on year, and operating profit reached KRW 3.47 billion, up 103.7%.

  3. 3

    Growth is coming from the 'other' segment that includes protein drinks, soy milk and coffee, and from exports; that segment reached 31.3% of Q3 2026 revenue, and the cumulative export share rose to 9.4% for January to September 2026.

  4. 4

    Q1 2026 net income attributable to controlling shareholders of KRW 6.31 billion was materially lifted by a one-off other non-operating gain, while Q3 2026 net income attributable to controlling shareholders of KRW 1.29 billion fell 37.8% year on year; earnings quality and cash flow are the next items to verify.

02

Business structure

Namyang Dairy Products started as a milk and infant formula business and is now expanding into protein drinks, soy milk and coffee.

In Q3 2026, segment revenue was KRW 129.1 billion for milk products, KRW 48 billion for infant formula, and KRW 80.6 billion for the 'other' segment covering protein drinks, soy milk and coffee.

Within the quarter, the milk products share of revenue fell from 54.8% a year earlier to 50.1%, while the other segment's share rose from 25.6% to 31.3%. Growth in the other segment was led by the Takefit protein brand, soy milk, cheese and the 17 Cha line.

In coffee, freeze-dried coffee, French Cafe and Lucas Nine expanded overseas sales. In milk products, functional items such as the lactose-free and low-fat variants of Masitneun Uyu GT supported a sequential revenue increase.

Infant formula is supplied mainly to Cambodia under the Imperial XO brand and the local StarGrow brand. Cumulative export share for January to September 2026 was 9.4%, up from 4.1% a year earlier. The subsidiary Baekmidang recorded Q3 2026 revenue of about KRW 8.7 billion and operating profit of about KRW 560 million.

In the first half of 2026, convenience store channel sales rose 10.1% and business-to-business channel sales rose 11%. Competition overlaps with listed Korean dairy companies in milk and formula, and with larger food and beverage makers in protein and coffee.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩237.5B₩1.7B0.7%
2025Q4₩229B₩2.5B1.1%
2026Q1₩225.2B₩500M0.2%
2026Q2₩258B₩1.3B0.5%
2026Q3₩257.6B₩3.5B1.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩964.7B-₩86.8B-₩78.4B−9.0%−10.6%22.3%
2023₩996.8B-₩72.4B-₩67.1B−7.3%−9.9%16.6%
2024₩952.8B-₩9.8B₩200M−1.0%0.0%14.6%
2025₩914.1B₩5.2B₩7.1B0.6%0.7%15.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue, as disclosed, was KRW 964.7 billion in 2022 and KRW 996.8 billion in 2023, up 3.3% year on year and the largest year of the period. It then fell 4.4% to KRW 952.8 billion in 2024 and 4.1% to KRW 914.1 billion in 2025, a two-year decline from 2024 through 2025, with 2025 the smallest year of the period.

Operating losses of KRW 86.8 billion in 2022 and KRW 72.4 billion in 2023 continued, with the loss narrowing to KRW 9.81 billion in 2024. Operating profit of KRW 5.17 billion in 2025 marked a turn to profitability, and the operating margin moved from -9.0% in 2022 to 0.6% in 2025.

Net loss attributable to controlling shareholders of KRW 78.4 billion in 2022 and KRW 67.1 billion in 2023 gave way to a KRW 250 million profit in 2024 and KRW 7.11 billion in 2025, up 2,743.4% year on year.

Quarterly operating profit went from KRW 1.7 billion in Q3 2025 and KRW 2.47 billion in Q4 2025 to a low of KRW 522 million in Q1 2026, then rose for two straight quarters to KRW 1.28 billion in Q2 and KRW 3.47 billion in Q3 2026.

Q3 2026 revenue of KRW 257.6 billion was up 8.5% year on year, and operating profit rose 103.7%. However, Q1 2026 net income attributable to controlling shareholders of KRW 6.31 billion was materially lifted by a KRW 8.27 billion protection-fund deposit booked as other non-operating income.

Q3 2026 net income attributable to controlling shareholders of KRW 1.29 billion fell 37.8% year on year, which the company attributed partly to exchange-rate effects.

Over the latest four quarters, net income attributable to controlling shareholders totaled KRW 12.1 billion, with more than half of that coming in Q1 2026. Operating cash flow for January to September 2026 was negative KRW 8.7 billion, compared with a net inflow of about KRW 23.8 billion in the same period of 2025.

05

Industry analysis

Dairy companies are reshaping their portfolios as drinking milk consumption declines and imports rise. The 0.8% year-on-year decline in milk product revenue in Q3 2026 fits this trend.

Infant formula demand depends on domestic birth numbers, which limits growth from home demand alone, so the company is expanding formula supply to Cambodia, Vietnam and Mongolia.

Protein drinks and coffee are growth categories across the broader food and beverage sector, and Namyang is widening overseas sales of Takefit and French Cafe. In May 2026 the company said its Chocoemong brand held the number one share of the domestic offline chocolate processed milk market for four consecutive years.

Competition in dairy comes from listed Korean dairy peers such as Maeil Dairies, while beverages and coffee compete with larger food and beverage makers. Revenue scale is far smaller than those large groups, so the company is pursuing differentiation in specific categories and overseas markets.

In the 2026 Korea ESG ratings, the integrated grade rose from B to B+, and the company kept a 'Excellent' grade in the 2026 Shared Growth Index for the fourth consecutive year.

06

Outlook

At its 62nd annual shareholders' meeting in March 2026, the company said it would make 2026 the first year of entering a stable growth trajectory.

At the same meeting it set out revenue expansion centered on growth channels and categories, profitability improvement, higher dividends and share buybacks and cancellations. Overseas, it signed an additional three-year agreement worth KRW 70 billion with a Vietnamese distributor in April 2026.

A KRW 10 billion export agreement with Mongolia was reported in July 2026, and Takefit and French Cafe have entered CU stores in Kazakhstan. The company is pursuing new customers in Vietnam and Indonesia and expanding its protein drink and strawberry dessert lines.

In August 2026 it said it would keep upgrading key distribution channels and strengthening growth categories in the second half. Baekmidang opened three new stores in Ilsan, Hwajeong and Dongtan in October 2026.

In the 2026 annual business report, the key checks are whether the operating margin moves away from 0.6% in 2025 and whether operating cash flow recovers from KRW 26.9 billion in 2025. Whether the overseas agreements convert into revenue will show up in the export share.

07

Valuation

PER
26.5×
PBR
0.3×
ROE
1.6%
EPS
₩1,562
BPS
₩120,860
Dividend per share
₩1,428

Price-to-book sits well below 1x, meaning the share price is low relative to book equity. Equity attributable to controlling shareholders was KRW 949.1 billion at the end of 2025, so the market valuation is low relative to net assets.

By contrast, the price-to-earnings multiple is high on the latest four quarters' net income attributable to controlling shareholders of KRW 12.1 billion, because the earnings base is small. Because profit is small, one-off items in individual quarters can move the multiple significantly.

Over several years, the direction is clear: a net loss in 2022 gave way to profit in 2025. The total dividend for the 2025 fiscal year was about KRW 11.2 billion, up about 1,250% from the prior year, and the full KRW 8.27 billion protection-fund amount was returned to shareholders as a special dividend. Dividend yield and multiples move with the share price, so they are best read alongside the earnings trend.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Quarterly profit recovery

Operating profit rose from a low of KRW 522 million in Q1 2026 to KRW 1.28 billion in Q2 and KRW 3.47 billion in Q3. Press reports put January to September 2026 operating profit at about KRW 5.3 billion, nearly double the prior-year period.

Reports attributed the margin improvement partly to lower selling and administrative expenses. Revenue growth and cost control appeared together.

Overseas and new product diversification

Cumulative exports for January to September 2026 reached about KRW 69.7 billion, above the full-year 2025 export total of KRW 39.6 billion. Exports in the other segment reached KRW 14.1 billion, about 9.2 times the prior-year figure. Takefit product sales rose 76.1% year on year in the first half of 2026. The three-year KRW 70 billion agreement with a Vietnamese distributor broadens the overseas revenue base.

Governance and shareholder returns

The 2026 Korea ESG ratings raised the integrated grade from B to B+. The company has held an 'Excellent' grade in the Shared Growth Index for four consecutive years. The total dividend for fiscal 2025 was about KRW 11.2 billion, up about 1,250%, and treasury shares acquired were cancelled.

The full protection-fund amount related to the former owner family was returned to shareholders as a special dividend.

09

Bear factors

A thin earnings base

The operating margin in 2025 was 0.6%, a low level. More than half of the KRW 12.1 billion in net income attributable to controlling shareholders over the latest four quarters came in Q1 2026. Q3 2026 net income attributable to controlling shareholders fell 37.8% year on year. Cost of sales grew faster than revenue, and the gross margin slipped from about 19.8% to 18.6%.

Cash flow and lower cash balance

Operating cash flow for January to September 2026 was negative KRW 8.7 billion, compared with a net inflow of about KRW 23.8 billion a year earlier. Cash on hand fell to KRW 28.8 billion. Shareholder returns of about KRW 31.3 billion were paid over the same period, more than the operating cash generated. Doubts about earnings quality remain until cash flow improves.

Shrinking core dairy

Milk product revenue in Q3 2026 was KRW 129.1 billion, down 0.8% year on year, and represented 50.1% of revenue. A declining trend in drinking milk consumption has been reported as an industry-wide challenge.

R&D spending for January to September 2026 was KRW 4.818 billion, down 3.0%, and its share of revenue fell from 0.72% to 0.65%.

10

Risk factors

Reliance on one-off items

Net income attributable to controlling shareholders of KRW 6.31 billion in Q1 2026 was materially lifted by a KRW 8.27 billion protection-fund amount booked as other non-operating income. Excluding such one-off items changes how quarterly earnings power reads.

Even as operating profit improves, net income can move sharply with exchange rates and non-operating items. Separating non-operating items in future quarterly reports is the key check.

Major shareholder sales and litigation

The largest shareholder's holding company sold 202,327 common shares on the open market from March to July 2026. The holding company has said the sales were meant to limit the rise in its stake that would come from treasury share cancellation.

A KRW 44.3 billion retirement-pay lawsuit involving the former chairman was reported as lost at first instance in August 2026. Governance uncertainty cannot yet be called fully resolved.

Exchange rates and cost pressure

Q3 2026 net income fell year on year, which the company attributed partly to exchange-rate effects. Cost of sales growth outpaced revenue growth, pressuring the gross margin. As the export share rises, exchange rates and overseas distribution terms carry more weight in results. Raw material and logistics costs may determine how fast the operating margin can improve.

11

What to watch next

  1. Mid-February 2027

    Whether preliminary full-year 2026 results are released. The 2025 preliminary results were announced on February 12, 2026. The comparison will be with 2025 revenue of KRW 914.1 billion and operating profit of KRW 5.17 billion.

  2. End of March 2027

    Filing of the 2026 annual business report. This sets the confirmed figures for annual revenue, operating margin (0.6% in 2025), operating cash flow (KRW 26.9 billion in 2025) and export share. Where preliminary figures differ, the confirmed filing is the reference.

  3. Around March 2027

    The 63rd annual shareholders' meeting and dividend decision. The 2026 meeting on March 27 approved an expanded dividend. Total dividend and treasury share cancellations will show whether shareholder returns are sustained.

  4. Mid-May 2027

    The Q1 2027 quarterly report. Q1 2026 results were announced on May 15 and included a one-off protection-fund item. Operating and net income excluding such items will show underlying quarterly strength.

12

Overall view

Namyang Dairy Products turned profitable at the operating level in 2025 with operating profit of KRW 5.17 billion, and operating profit rose in Q2 and Q3 2026 from a Q1 low of KRW 522 million.

Growth is coming from the other segment covering protein drinks, soy milk and coffee, which reached 31.3% of Q3 2026 revenue, and from exports, which reached 9.4% of revenue cumulatively for January to September 2026.

On the other side, the earnings base is small, with net income attributable to controlling shareholders of KRW 12.1 billion over the latest four quarters, more than half of it in Q1 2026, which included a one-off gain. Operating cash flow for January to September 2026 worsened to negative KRW 8.7 billion.

Shareholder returns expanded, with total dividends of about KRW 11.2 billion and a special dividend, but the balance between cash on hand and shareholder payouts is a key variable. The decline in R&D spending and the shrinking milk share are also relevant to medium-term competitiveness.

The next checks are the operating margin and operating cash flow in the 2026 annual business report, which will show whether profitability and cash generation improve together.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. zdnet.co.kr
  2. hankyung.com
  3. insight.co.kr
  4. biztribune.co.kr
  5. webeconomy.co.kr
  6. ziksir.com
  7. news.jkn.co.kr
  8. etoday.co.kr
  9. newsway.co.kr
  10. newsquest.co.kr
  11. news.nate.com
  12. news.nate.com
  13. news.nate.com
  14. m.news.nate.com
  15. etoday.co.kr
  16. youthdaily.co.kr
  17. vegannews.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis